Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment

您当前的位置：

首页 >

文章列表页 >

Full-length article | 更新时间：2023-05-16

- Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment
- Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment
- Genes & Diseases 2023年10卷第2期
- 作者机构：
  
  Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences,Beijing,China,100700
- 作者简介：
- 基金信息：
- DOI：10.1016/j.jtcms.2023.02.004
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-4-1，
扫描看全文
Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment[J]. Genes & Diseases, 2023,10(2).

Xing Liao, Xue Wu, Zhong Wang, et al. Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment[J]. Genes & Diseases, 2023,10(2).
Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.02.004.

Xing Liao, Xue Wu, Zhong Wang, et al. Shaoma Zhijing granule for children with tic disorders: A rapid health technology assessment[J]. Genes & Diseases, 2023,10(2). DOI： 10.1016/j.jtcms.2023.02.004.

ObjectiveTo rapidly assess the effectiveness

safety

economy

and applicability of Shaoma Zhijing granule (SZG) for the treatment of children with tic disorders (TD)

and provide currently available best evidence for decision-makers of health policies.

Shaoma Zhijing granuleTic disordersChildrenRapid health technology assessmentQuality assessment

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据